Peterson Katharine (CIK 2022214) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-20). Recent activity: Buy ACRV (14,227 shares), Sell ACRV (99 shares), Sell ACRV (116 shares), Sell ACRV (99 shares), Sell ACRV (99 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-20 | Acrivon Therapeutics, Inc. (ACRV) | Chief Accounting Officer | Buy | 14,227 | $0 |
| 2026-05-18 | Acrivon Therapeutics, Inc. (ACRV) | Chief Accounting Officer | Sell | 99 | $190 |
| 2026-02-18 | Acrivon Therapeutics, Inc. (ACRV) | Chief Accounting Officer | Sell | 116 | $189 |
| 2025-11-18 | Acrivon Therapeutics, Inc. (ACRV) | Chief Accounting Officer | Sell | 99 | $222 |
| 2025-08-18 | Acrivon Therapeutics, Inc. (ACRV) | Chief Accounting Officer | Sell | 99 | $138 |
| 2025-05-16 | Acrivon Therapeutics, Inc. (ACRV) | Chief Accounting Officer | Sell | 99 | $113 |
| 2025-02-19 | Acrivon Therapeutics, Inc. (ACRV) | Chief Accounting Officer | Sell | 116 | $629 |
Source: SEC Form 4 filings · as of 2026-05-20